Fig. 1
From: NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma
Associations between IL6/IL6R expression and the clinic-pathologic features of gliomas. a–b The expression of IL6R (a) and IL6 (b) were shown according to molecular subtypes of TCGA gliomas. c–d The expression of IL6R (c) and IL6 (d) were shown according to IDH status of TCGA gliomas. e–f Prognostic significance of IL6R in TCGA gliomas (e) and GBMs (f). g The prognostic significance of IL6R was validated in REMBRANDT gliomas. h–i Prognostic significance of IL6 in TCGA gliomas (h) and GBMs (i). j The prognostic significance of IL6 was confirmed in REMBRANDT gliomas. ***P < 0.001. Classical, CL; neural, NE; proneural, PN; mesenchymal, ME